Netscientific Share Discussion Threads

[matt123d] 07/10/2020 10:17

Anyone's guess but 80-90 would be the next obvious area if it can get through last months highs.

[catchingmice] 07/10/2020 10:07

What's the potential spike figure ?80-90 or more ?

[matt123d] 07/10/2020 10:01

Gets above 73p then potential for one of its spikes

[matt123d] 07/10/2020 10:00

Wow, movement and upwards!

[catchingmice] 07/10/2020 09:51

27k Buy there at 62Not punt money surely

[catchingmice] 07/10/2020 09:38

Some movement for once Let's see how it goes

[the stigologist] 06/10/2020 22:59

wow these PDSB October 2020 Presentation slides... inject them into my veins

[samsung2020] 06/10/2020 14:02

Thanks Trooter, not heard much from them in a while, update is due

[trotterstrading] 06/10/2020 10:52

Bit of patience needed that's all.

[samsung2020] 05/10/2020 16:01

Seems to have gone a tad stale again thought it had started brewing when back upto 71 but nothing came of it... thoughts on this anyone?

[the stigologist] 03/10/2020 13:21

Biotech been in a bull market huh ?

[the stigologist] 01/10/2020 14:28

NSCI/PDSB onto a winner with this cancer vaccine space

[the stigologist] 01/10/2020 08:30

Wow Vaccibody which entered Phase I trials last year with Roche IO drug Tecentriq now signs $715m deal with Roche Genentech !




Vaccibody is a PDS Biotech comparator

[the stigologist] 30/9/2020 18:57

Typical holding pattern pre news and volume breakout to upside

[jusjusjus] 30/9/2020 11:14

holders sell into it?

why news from 25th Aug only coming out now?

[the stigologist] 30/9/2020 11:13

So two big insiders own 50%

LOL

What do people think happens when we get news ?

[the stigologist] 29/9/2020 08:17

chart looking good

[the stigologist] 28/9/2020 20:04

FLORHAM PARK, N.J., Sept. 28, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotech” or the “Company”) (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced that its Chief Medical Officer, Lauren V. Wood, M.D. will present key data from the company’s previously reported Phase 1 trial of PDS0101 and planned Phase 2 clinical studies in patients with advanced HPV-associated malignancies at the World Vaccine Congress, being held virtually September 28 – October 1, 2020.

Abstract: Versamune® Plus Multi-Epitopic HPV16 Peptides in the Treatment of HPV-Associated Cancers

Session: Cancer & Immunotherapy, Viral Associated Cancers

Date: Wednesday, September 30, 2020



Time: 2:05 p.m. ET

[jibba jabber] 27/9/2020 06:28

Looks bad, expecting a sharp downward correction on Monday, i'm hearing a .4 placing coming, massive dilution.

[peakytraders_14] 24/9/2020 20:50

You are the weakest link....Good Bye

[tangerine_dream] 24/9/2020 16:44

Hello Bum Bandit RK23, see you in the loos!!!